HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo

Adoptive cellular immunotherapy therapy using broadly neutralizing antibody-based chimeric antigen receptor-T cells (bNAb-based CAR-T) has shown great potency and safety for the functional cure of HIV. The efficacy of bNAb-based CAR-T cells could be compromised by adaptive resistance during HIV chro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhengtao, Liang, Huitong, Pan, Hanyu, Liang, Yue, Wang, Hua, Yang, Xinyi, Lu, Panpan, Zhang, Xiao, Yang, Jinlong, Zhang, Dengji, Shen, Xiaoting, Wang, Jing, Liang, Zhiming, Lin, Qinru, Wang, Yanan, Zhao, Lin, Zhong, Yangcheng, Lu, Hongzhou, Zhu, Huanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290485/
https://www.ncbi.nlm.nih.gov/pubmed/34295319
http://dx.doi.org/10.3389/fmicb.2021.684016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290485/
https://www.ncbi.nlm.nih.gov/pubmed/34295319
http://dx.doi.org/10.3389/fmicb.2021.684016

Ejemplares similares